An Update on Multi-System Inflammatory Syndrome in Children

Area of Science:

• Pediatric infectious diseases
• Immunology
• Cardiology

Background:

• Multisystem inflammatory syndrome in children (MIS-C) emerged during the COVID-19 pandemic.
• Its epidemiology, pathogenesis, and clinical course have been subjects of intense research.

Purpose of the Study:

• To synthesize current knowledge on MIS-C, covering epidemiology, pathogenesis, diagnosis, and treatment.
• To highlight recent advancements and ongoing research questions.

Main Methods:

• Literature review of recent studies on MIS-C.
• Analysis of epidemiological trends, diagnostic criteria evolution, and therapeutic strategies.
• Evaluation of immunologic findings and long-term outcomes.

Main Results:

• MIS-C epidemiology is dynamic; prevalence and severity have decreased, but disparities persist.
• Pathogenesis remains unclear, though an immunologic signature is emerging.
• Treatment approaches vary, with corticosteroids showing promise. Long-term cardiac changes are noted despite initial improvements.

Conclusions:

• COVID-19 vaccination significantly reduces MIS-C incidence.
• Distinguishing MIS-C from Kawasaki Disease (KD) is crucial with updated definitions.
• Ongoing research is vital for understanding long-term sequelae and optimizing management.